학술논문

Why Cockayne syndrome patients do not get cancer despite their DNA repair deficiency
Document Type
article
Source
Proceedings of the National Academy of Sciences of the United States of America. 113(36)
Subject
Biological Sciences
Bioinformatics and Computational Biology
Biomedical and Clinical Sciences
Genetics
Rare Diseases
Climate-Related Exposures and Conditions
Cancer
Aetiology
2.1 Biological and endogenous factors
Cockayne Syndrome
DNA
DNA Breaks
Double-Stranded
DNA Repair
Fibroblasts
Healthy Volunteers
Humans
Keratinocytes
Mutation
Primary Cell Culture
Sequence Analysis
DNA
Skin Neoplasms
Ultraviolet Rays
Xeroderma Pigmentosum
mutagenesis
dipyrimidines
transcription arrest
apoptosis
RNA pol II
Language
Abstract
Cockayne syndrome (CS) and xeroderma pigmentosum (XP) are human photosensitive diseases with mutations in the nucleotide excision repair (NER) pathway, which repairs DNA damage from UV exposure. CS is mutated in the transcription-coupled repair (TCR) branch of the NER pathway and exhibits developmental and neurological pathologies. The XP-C group of XP patients have mutations in the global genome repair (GGR) branch of the NER pathway and have a very high incidence of UV-induced skin cancer. Cultured cells from both diseases have similar sensitivity to UV-induced cytotoxicity, but CS patients have never been reported to develop cancer, although they often exhibit photosensitivity. Because cancers are associated with increased mutations, especially when initiated by DNA damage, we examined UV-induced mutagenesis in both XP-C and CS cells, using duplex sequencing for high-sensitivity mutation detection. Duplex sequencing detects rare mutagenic events, independent of selection and in multiple loci, enabling examination of all mutations rather than just those that confer major changes to a specific protein. We found telomerase-positive normal and CS-B cells had increased background mutation frequencies that decreased upon irradiation, purging the population of subclonal variants. Primary XP-C cells had increased UV-induced mutation frequencies compared with normal cells, consistent with their GGR deficiency. CS cells, in contrast, had normal levels of mutagenesis despite their TCR deficiency. The lack of elevated UV-induced mutagenesis in CS cells reveals that their TCR deficiency, although increasing cytotoxicity, is not mutagenic. Therefore the absence of cancer in CS patients results from the absence of UV-induced mutagenesis rather than from enhanced lethality.